{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Detroit&page=34&state=Michigan", "query": { "state": "Michigan", "city": "Detroit", "page": 34 }, "page_size": 10 }, "pagination": { "page": 34, "page_size": 10, "total_count": 7238, "total_pages": 724, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Detroit&page=35&state=Michigan&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Detroit&page=33&state=Michigan&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-01T21:44:16.087Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06868212", "title": "A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Spontaneous Urticaria (CSU)" ], "interventions": [ { "name": "Remibrutinib", "type": "DRUG" }, { "name": "Remibrutinib matching placebo", "type": "DRUG" }, { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo solution for injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 409, "start_date": "2025-07-11", "completion_date": "2027-05-17", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 121, "location_summary": "Birmingham, Alabama • Litchfield Park, Arizona • Payson, Arizona + 98 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Payson", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06868212" }, { "nct_id": "NCT00802100", "title": "Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Olanzapine", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Simvastatin", "type": "DRUG" }, { "name": "Benztropine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 21, "start_date": "2008-12", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2013-02-08", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 13, "location_summary": "Colton, California • Palo Alto, California • New Haven, Connecticut + 10 more", "locations": [ { "city": "Colton", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00802100" }, { "nct_id": "NCT00992836", "title": "Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections", "H1N1 Influenza Virus" ], "interventions": [ { "name": "Influenza A (H1N1) 2009 monovalent vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "4 Years to 25 Years" }, "enrollment_count": 155, "start_date": "2009-10", "completion_date": "2010-08", "has_results": true, "last_update_posted_date": "2021-11-05", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Alhambra, California • La Jolla, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Alhambra", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00992836" }, { "nct_id": "NCT01596036", "title": "Readiness for Behavior Change After a Heart Attack", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Myocardial Infarction", "Stable Angina", "Coronary Artery Disease" ], "interventions": [ { "name": "Early appointment (within 10 days)", "type": "BEHAVIORAL" }, { "name": "Routine referral (at 5 weeks)", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2011-02", "completion_date": "2012-11", "has_results": false, "last_update_posted_date": "2012-11-14", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01596036" }, { "nct_id": "NCT00874211", "title": "S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Lung Cancer", "Metastatic Cancer", "Multiple Myeloma", "Plasma Cell Neoplasm", "Prostate Cancer", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "assessment of therapy complications", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "120 Years", "sex": "ALL", "summary": "Up to 120 Years" }, "enrollment_count": 3571, "start_date": "2008-12", "completion_date": "2019-06", "has_results": false, "last_update_posted_date": "2019-07-05", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 451, "location_summary": "Anniston, Alabama • Mobile, Alabama • Anchorage, Alaska + 302 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Fairbanks", "state": "Alaska" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00874211" }, { "nct_id": "NCT01331005", "title": "NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "nepafenac 0.1% drops", "type": "DRUG" }, { "name": "Nepafenac Vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Jaeb Center for Health Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2011-05", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2025-03-10", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 32, "location_summary": "Loma Linda, California • Palm Springs, California • Santa Barbara, California + 29 more", "locations": [ { "city": "Loma Linda", "state": "California" }, { "city": "Palm Springs", "state": "California" }, { "city": "Santa Barbara", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Westlake Village", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01331005" }, { "nct_id": "NCT02813694", "title": "Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Community Acquired Pneumonia" ], "interventions": [ { "name": "lefamulin", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nabriva Therapeutics AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 738, "start_date": "2016-08", "completion_date": "2018-01", "has_results": true, "last_update_posted_date": "2019-10-23", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 25, "location_summary": "Beverly Hills, California • Fresno, California • Northridge, California + 20 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Oxnard", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02813694" }, { "nct_id": "NCT02163694", "title": "A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Breast Cancer" ], "interventions": [ { "name": "Veliparib Placebo", "type": "DRUG" }, { "name": "Veliparib", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 513, "start_date": "2014-04-08", "completion_date": "2024-01-25", "has_results": true, "last_update_posted_date": "2025-02-19", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 56, "location_summary": "Gilbert, Arizona • Little Rock, Arkansas • Duarte, California + 48 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Duarte", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02163694" }, { "nct_id": "NCT00002622", "title": "Talc in Treating Patients With Malignant Pleural Effusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Cancer" ], "interventions": [ { "name": "Talc", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 501, "start_date": "1994-12", "completion_date": "2006-01", "has_results": false, "last_update_posted_date": "2016-06-28", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 224, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 174 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002622" }, { "nct_id": "NCT02775851", "title": "Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Desmoplastic Melanoma" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Elastography", "type": "PROCEDURE" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Therapeutic Conventional Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2017-02-06", "completion_date": "2027-05-15", "has_results": true, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-11-01T21:44:16.087Z", "location_count": 280, "location_summary": "Fairbanks, Alaska • Phoenix, Arizona • Fort Smith, Arkansas + 199 more", "locations": [ { "city": "Fairbanks", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Arroyo Grande", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02775851" } ] }